ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹128 Cr | ₹96 Cr | ₹90 Cr | ₹68 Cr | ₹59 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹128 Cr |
| Mar2024 | ₹96 Cr |
| Mar2023 | ₹90 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹59 Cr |
How is Total Current Liabilities of ALEMBIC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹128 Cr | 32.75 | |
| Mar2024 | ₹96 Cr | 7.31 | |
| Mar2023 | ₹90 Cr | 32.16 | |
| Mar2022 | ₹68 Cr | 14.05 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,017.4 Cr | -3.1% | -17.9% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -3.1% |
-17.9% |
-12.2% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses